V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006578 | 290004945 | null | null | Palliative (P) | 2016-10-08 | 2016-10-15 | Cisplatin + Radiotherapy | N | null | 290019693 | CAPECITABINE + CISPLATIN + STREPTOZOCIN |
| 290006579 | 290004945 | 1.55 | 77.2 | Adjuvant (A) | 2016-05-22 | 2016-05-28 | Trastuzumab + VINORELBINE | Y | N | 290019693 | CAPECITABINE |
| 290006580 | 290004946 | 1.66 | null | Curative (C) | 2016-07-07 | 2016-07-30 | CETUXIMAB | N | Y | 290019717 | CISPLATIN + RT |
| 290006581 | 290004947 | null | 77.4 | Palliative (P) | 2016-01-06 | 2016-02-28 | LANREOTIDE | N | N | 290019719 | CAPECITABINE + CARBOPLATIN |
| 290006582 | 290004948 | 1.76 | 99.3 | Adjuvant (A) | 2015-03-21 | 2015-03-28 | Capecitabine | N | N | 290019723 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 290006583 | 290004948 | 1.78 | null | Curative (C) | null | 2017-06-09 | Cisplatin 7 day | null | null | 290019723 | CISPLATIN + RT |
| 290006584 | 290004949 | 1.81 | 94.5 | Adjuvant (A) | 2017-12-13 | 2017-12-13 | Capecitabine 35days + RT | 02 | N | 290019730 | CAPECITABINE |
| 290006585 | 290004950 | 1.9 | 69.45 | null | 2015-09-24 | 2015-09-24 | Trial Unspecified | 02 | 2 | 290019730 | Y-90 |
| 290006586 | 290007955 | 1.73 | 101 | Neo-adjuvant (N) | 2016-06-29 | 2016-12-15 | Hydroxycarbamide | 2 | Y | 290019745 | NOT MATCHED |
| 290006587 | 290004951 | 1.71 | 107 | Palliative (P) | 2018-03-03 | 2018-03-06 | Cisplatin + Radiotherapy | N | N | 290019752 | CARBOPLATIN + CETUXIMAB + FU |
| 290006588 | 290004952 | 1.92 | 90 | Not known (9) | 2017-01-14 | 2017-01-14 | Sunitinib | N | N | 290019760 | LANREOTIDE |
| 290006589 | 290004952 | 1.63 | 47.4 | null | 2017-12-13 | 2017-12-13 | Capecitabine | N | Y | 290019760 | CAPECITABINE + OXALIPLATIN |
| 290006590 | 290007956 | 1.71 | 56.45 | Curative (C) | 2016-08-16 | 2016-09-12 | Capecitabine (14 day) + Irinotecan | N | Y | 290019766 | CETUXIMAB + RT |
| 290006591 | 290007956 | 1.64 | 43.35 | Palliative (P) | 2017-09-13 | 2018-03-08 | CARBOPLATIN + ETOPOSIDE | null | N | 290019766 | CAPECITABINE |
| 290006592 | 290004953 | 1.83 | 94.5 | Curative (C) | 2016-05-03 | 2016-06-13 | CHOP R - 21 days | N | Y | 290019773 | RITUXIMAB |
| 290006593 | 290004955 | 1.6 | 54.5 | Curative (C) | 2018-04-14 | 2018-04-27 | Capecitabine | N | N | 290019778 | CISPLATIN + RT |
| 290006594 | 290004956 | 1.52 | 46.3 | Curative (C) | 2018-09-07 | 2018-09-07 | FCarboSt | 02 | Y | 290019781 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290006595 | 290004957 | 1.69 | 56.9 | Adjuvant (A) | 2018-01-04 | 2018-02-27 | Trastuzumab + VINORELBINE | 02 | null | 290019781 | TRASTUZUMAB |
| 290006596 | 290004958 | 1.76 | 56 | Adjuvant (A) | 2015-10-03 | 2015-10-03 | LANREOTIDE | 02 | N | 290019787 | CAPECITABINE + RT |
| 290006597 | 290004959 | 1.69 | null | Curative (C) | 2014-05-17 | 2014-06-14 | MITOMYCIN | N | N | 290019788 | CISPLATIN + RT |
| 290006598 | 290007096 | 1.62 | 67.25 | Curative (C) | 2014-04-07 | 2014-07-10 | CARBOPLATIN + VINORELBINE | 02 | N | 290019795 | CAPECITABINE + OXALIPLATIN |
| 290006599 | 290004962 | 0 | 73.2 | Palliative (P) | 2014-12-26 | 2015-01-08 | Paclitaxel 7 day | N | N | 290019798 | CETUXIMAB |
| 290006600 | 290004963 | 1.54 | 70.4 | Palliative (P) | 2016-11-20 | 2017-09-27 | Trial Unspecified | N | N | 290019798 | TRIAL |
| 290006601 | 290007957 | 1.53 | 54.9 | Curative (C) | 2017-12-02 | 2017-12-03 | PACLITAXEL | N | Y | 290019805 | CHOP R |
| 290006602 | 290004964 | 1.62 | 43.8 | Palliative (P) | 2015-08-30 | 2015-08-31 | Ipilimumab | 2 | N | 290019809 | CAPECITABINE |
| 290006603 | 290004965 | 1.8 | 60.05 | Curative (C) | 2017-03-09 | 2017-03-16 | Capecitabine | 02 | null | 290019811 | CARBOPLATIN + RT |
| 290006604 | 290004967 | 1.87 | null | Palliative (P) | 2018-04-25 | 2018-04-25 | Capecitabine | 02 | null | 290019811 | CETUXIMAB |
| 290006605 | 290004967 | 1.71 | 83 | Palliative (P) | 2015-10-30 | 2015-11-02 | Sunitinib | N | N | 290019811 | CETUXIMAB + CISPLATIN + FU |
| 290006606 | 290004968 | null | 108.7 | Curative (C) | 2013-12-19 | 2013-12-19 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | N | N | 290019829 | IVE |
| 290006607 | 290004969 | 1.85 | null | null | 2013-03-09 | 2013-03-20 | CAPECITABINE + MITOMYCIN + RT | null | N | 290019830 | CETUXIMAB + RT |
| 290006608 | 290004970 | 1.6 | null | Adjuvant (A) | 2017-02-11 | 2017-03-10 | OXALIPLATIN + MDG + PANITUMUMAB | null | N | 290019846 | CISPLATIN + RT |
| 290006609 | 290004971 | 1.7 | 116.2 | Palliative (P) | null | 2016-10-02 | Capecitabine + Mitomycin | 02 | Y | 290019854 | CAPECITABINE + CISPLATIN |
| 290006610 | 290004972 | null | null | Palliative (P) | 2016-12-16 | 2016-12-21 | Cisplatin 100 + RT(H&N) 1 day | N | null | 290019873 | LANREOTIDE |
| 290006611 | 290004972 | 1.76 | 54 | Adjuvant (A) | 2017-06-25 | 2017-07-10 | MCX | 2 | N | 290019873 | CAPECITABINE + RT |
| 290006612 | 290004973 | 1.67 | 63.5 | Adjuvant (A) | null | 2014-10-11 | CompARE Trial | N | N | 290019878 | TRASTUZUMAB |
| 290006613 | 290004974 | 1.76 | 60.2 | null | 2015-04-21 | 2015-05-05 | CHOP R - 21 days | null | N | 290019905 | LANREOTIDE |
| 290006614 | 290004975 | 1.71 | 96.1 | Disease modification (D) | 2015-10-29 | 2015-10-29 | CARBOPLATIN + RT | 02 | Y | 290019907 | LANREOTIDE |
| 290006615 | 290004976 | 1.87 | 68.2 | Palliative (P) | 2017-10-16 | 2018-09-12 | Cisplatin 7 day | 02 | N | 290019910 | TRIAL |
| 290006616 | 290004977 | 1.6 | 50.3 | Neo-adjuvant (N) | 2014-10-03 | 2015-06-26 | IGEV R | null | N | 290019911 | CISPLATIN |
| 290006617 | 290004978 | 1.5 | 62 | Adjuvant (A) | 2017-07-27 | 2017-08-10 | Cetuximab 7 day (>Cycle 2) | N | N | 290019915 | CAPECITABINE + OXALIPLATIN |
| 290006618 | 290007101 | 1.71 | 76.2 | Curative (C) | 2016-06-18 | 2016-06-18 | PACLITAXEL | 2 | N | 290019949 | CARBOPLATIN |
| 290006619 | 290004980 | null | null | Curative (C) | 2018-01-17 | 2018-01-18 | Trabectedin | N | null | 290019949 | FLUOROURACIL + MITOMYCIN |
| 290006620 | 290004983 | 1.74 | 62 | Curative (C) | 2018-03-22 | 2018-04-06 | Irinotecan | N | null | 290019957 | CETUXIMAB + CISPLATIN + FU |
| 290006621 | 290004984 | null | 60.3 | Adjuvant (A) | 2017-05-01 | 2017-05-01 | Capecitabine | 02 | N | 290019960 | TRASTUZUMAB |
| 290006622 | 290004985 | 1.58 | 0 | Palliative (P) | 2015-01-12 | 2015-01-12 | Irinotecan | 2 | null | 290019975 | DOCETAXEL |
| 290006623 | 290004986 | 1.69 | 60.5 | null | 2016-01-05 | 2016-01-27 | MITOMYCIN | 02 | null | 290019976 | CETUXIMAB + RT |
| 290006624 | 290004987 | 1.65 | 68 | Curative (C) | null | 2017-06-24 | CAPECITABINE + MITOMYCIN + RT | N | N | 290019995 | CAPECITABINE |
| 290006625 | 290004988 | 1.7 | 54.6 | Palliative (P) | 2013-08-31 | 2013-10-20 | null | 02 | N | 290019998 | PANITUMUMAB |
| 290006626 | 290004990 | 1.77 | 84.9 | Neo-adjuvant (N) | 2014-01-14 | 2014-01-14 | Capecitabine + Oxaliplatin 21day | N | null | 290020002 | CAPECITABINE + RT |
| 290006627 | 290004990 | 1.58 | null | Palliative (P) | 2018-07-04 | 2018-07-13 | CARBOPLATIN + PACLITAXEL | N | N | 290020002 | CETUXIMAB + CISPLATIN + FLUOROURACIL |